FLECTOR Drug Patent Profile
✉ Email this page to a colleague
When do Flector patents expire, and what generic alternatives are available?
Flector is a drug marketed by Inst Biochem and is included in one NDA.
The generic ingredient in FLECTOR is diclofenac epolamine. There are forty-seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the diclofenac epolamine profile page.
Summary for FLECTOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Clinical Trials: | 5 |
| Patent Applications: | 103 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FLECTOR |
| Drug Sales Revenues: | Drug sales revenues for FLECTOR |
| What excipients (inactive ingredients) are in FLECTOR? | FLECTOR excipients list |
| DailyMed Link: | FLECTOR at DailyMed |
Recent Clinical Trials for FLECTOR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fidia Farmaceutici s.p.a. | Phase 3 |
| Fidia Farmaceutici s.p.a. | Phase 1 |
| Actavis Inc. | Phase 3 |
Pharmacology for FLECTOR
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
| Physiological Effect | Decreased Prostaglandin Production |
Anatomical Therapeutic Chemical (ATC) Classes for FLECTOR
Paragraph IV (Patent) Challenges for FLECTOR
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| FLECTOR | Topical Patch | diclofenac epolamine | 1.3% | 021234 | 1 | 2015-06-26 |
US Patents and Regulatory Information for FLECTOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inst Biochem | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FLECTOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Inst Biochem | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
| Inst Biochem | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FLECTOR
See the table below for patents covering FLECTOR around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| South Africa | 8708405 | ⤷ Try a Trial | |
| Australia | 8117587 | ⤷ Try a Trial | |
| European Patent Office | 0621263 | Préparation pour sparadrap analgésique et anti-inflammatoire externe (External anti-inflammatory and analgesic plaster preparation) | ⤷ Try a Trial |
| Canada | 2121065 | PREPARATION POUR PLATRE EXTERNE ANTI-INFLAMMATOIRE ET ANALGESIQUE (EXTERNAL ANTI-INFLAMMATORY AND ANALGESIC PLASTER PREPARATION) | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
NCE-1 Patent Challenge Dates 2023 - 2024
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
